Figure 6.

OS by predefined subgroups. aPatients were considered del(17p) positive if any cell was positive; *Interaction P‐value corresponds to del(17p) (yes) versus del(17p) (no); †Interaction P‐value corresponds to t(4:14) (yes) versus t(4:14) (no). CI, confidence interval; ELd, elotuzumab + lenalidomide/dexamethasone; HR, hazard ratio; IMiD, immunomodulatory drug; ISS, International Staging System; Ld, lenalidomide/dexamethasone; OS, overall survival.